These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12832110)

  • 1. Proceedings of the 4th International Meeting on New Approaches to Bacterial Vaccine Development. Munich, Germany, 27-29 May 2002.
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):85-200. PubMed ID: 12832110
    [No Abstract]   [Full Text] [Related]  

  • 2. New approaches to bacterial vaccine development. Proceedings of the 3rd International Meeting. Munich, Germany, 19-22 May 1999.
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):iii, 275-364. PubMed ID: 10809561
    [No Abstract]   [Full Text] [Related]  

  • 3. New approaches in vaccine development, 1999 (NAVD'99, 15-18 may, 1999, Vienna, Austria) and new approaches to bacterial vaccine development (NABVD'99, 19-22 may 1999, Munich, Germany).
    Lubitz W; von Specht B
    J Biotechnol; 2000 Sep; 83(1-2):1-2. PubMed ID: 11000452
    [No Abstract]   [Full Text] [Related]  

  • 4. 4th International Symposium on New Quinolones. Proceedings. Munich, Germany, August 27-29, 1992.
    Drugs; 1993; 45 Suppl 3():1-475. PubMed ID: 7689438
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral immunization using recombinant bacteria. International symposium. Munich, June 6-7, 1990. Proceedings.
    Res Microbiol; 1990; 141(7-8):745-1025. PubMed ID: 1983203
    [No Abstract]   [Full Text] [Related]  

  • 6. Genome-based approaches to develop vaccines against bacterial pathogens.
    Serruto D; Serino L; Masignani V; Pizza M
    Vaccine; 2009 May; 27(25-26):3245-50. PubMed ID: 19200820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESR dosimetry and applications. Proceedings of the 4th International Symposium. Munich, Germany, 15-19 May 1995.
    Appl Radiat Isot; 1996; 47(11-12):1151-687. PubMed ID: 9081589
    [No Abstract]   [Full Text] [Related]  

  • 8. Fast vaccine design and development based on correlates of protection (COPs).
    van Els C; Mjaaland S; Næss L; Sarkadi J; Gonczol E; Korsholm KS; Hansen J; de Jonge J; Kersten G; Warner J; Semper A; Kruiswijk C; Oftung F
    Hum Vaccin Immunother; 2014; 10(7):1935-48. PubMed ID: 25424803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological Approaches to Tumor Therapy. Proceedings of the 4th International Meeting on Idiotypic Network and Tumor Therapy by Gene Therapy and Drug Targeting. Bonn, Germany, March 6-7, 1998.
    Hybridoma; 1999 Feb; 18(1):1-112. PubMed ID: 10454869
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of the International Symposium on Tuberculosis Vaccine Development and Evaluation. 26-28 August 1998, San Francisco, California, USA.
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S199-322. PubMed ID: 10875782
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteomic Forum 2003. Proceedings of the international meeting on proteome analysis. September 14-17, 2003, Munich, Germany.
    Proteomics; 2004 May; 4(5):1235-420. PubMed ID: 15188423
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings of the 1st International Meeting on Molecular Staging of Cancer. Munich, Germany, December 6-8, 2001.
    Recent Results Cancer Res; 2003; 162():1-217. PubMed ID: 13677331
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacterial infectious disease control by vaccine development.
    Curtiss R
    J Clin Invest; 2002 Oct; 110(8):1061-6. PubMed ID: 12393839
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacterial genomics and vaccine design.
    Sampson SL; Rengarajan J; Rubin EJ
    Expert Rev Vaccines; 2003 Jun; 2(3):437-45. PubMed ID: 12903808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current tuberculosis vaccine development.
    Young DB
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S254-6. PubMed ID: 10875794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to the rational design of bacterial vaccines.
    Hambleton P; Prior SD; Robinson A
    Prog Drug Res; 1988; 32():377-409. PubMed ID: 3064186
    [No Abstract]   [Full Text] [Related]  

  • 17. The implications of vaccines for prevention of bacterial meningitis.
    Riordan A
    Curr Opin Neurol; 2010 Jun; 23(3):319-24. PubMed ID: 20173637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic technology in the design of new effective antibacterial vaccines.
    Jagusztyn-Krynicka EK; Dadlez M; Grabowska A; Roszczenko P
    Expert Rev Proteomics; 2009 Jun; 6(3):315-30. PubMed ID: 19489702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper associated liver diseases in infancy and childhood. Proceedings of the 4th Emma-Thaler Symposium held at the Department of Paediatrics, Munich University Medical School, Dr. von Hauner'sches Kinderspital, Munich, Germany.
    Weser U
    Eur J Med Res; 1999 Jul; 4(7):300. PubMed ID: 10523118
    [No Abstract]   [Full Text] [Related]  

  • 20. Genome-based vaccine development: a short cut for the future.
    Moriel DG; Scarselli M; Serino L; Mora M; Rappuoli R; Masignani V
    Adv Exp Med Biol; 2009; 655():81-9. PubMed ID: 20047037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.